# Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

> **NCT06005168** · PHASE4 · COMPLETED · sponsor: **University of Michigan** · enrollment: 57 (actual)

## Conditions studied

- Surgical Prophylaxis

## Interventions

- **DRUG:** Cefazolin for Injection

## Key facts

- **NCT ID:** NCT06005168
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-08
- **Primary completion:** 2025-10-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005168

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005168, "Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06005168. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*